Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 5 | 2018 | 267 | 2.090 |
Why?
|
| Laparoscopy | 12 | 2022 | 754 | 1.800 |
Why?
|
| Proctocolectomy, Restorative | 10 | 2022 | 87 | 1.540 |
Why?
|
| Rectal Neoplasms | 4 | 2021 | 116 | 1.300 |
Why?
|
| Rectum | 4 | 2018 | 146 | 1.290 |
Why?
|
| Inflammatory Bowel Diseases | 9 | 2021 | 549 | 1.110 |
Why?
|
| Colitis, Ulcerative | 10 | 2022 | 711 | 1.100 |
Why?
|
| Robotics | 3 | 2018 | 267 | 0.950 |
Why?
|
| Colon | 3 | 2018 | 496 | 0.910 |
Why?
|
| Crohn Disease | 9 | 2022 | 730 | 0.900 |
Why?
|
| Colonic Pouches | 6 | 2022 | 67 | 0.870 |
Why?
|
| Anastomotic Leak | 4 | 2018 | 96 | 0.800 |
Why?
|
| Colectomy | 6 | 2022 | 167 | 0.770 |
Why?
|
| Learning Curve | 2 | 2018 | 18 | 0.760 |
Why?
|
| Colorectal Neoplasms | 5 | 2022 | 938 | 0.700 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2018 | 120 | 0.600 |
Why?
|
| Credentialing | 1 | 2017 | 13 | 0.600 |
Why?
|
| Surgical Flaps | 2 | 2016 | 241 | 0.570 |
Why?
|
| Rectovaginal Fistula | 1 | 2016 | 7 | 0.570 |
Why?
|
| Rectus Abdominis | 1 | 2015 | 37 | 0.530 |
Why?
|
| Anal Canal | 2 | 2016 | 89 | 0.520 |
Why?
|
| Intestinal Mucosa | 2 | 2016 | 797 | 0.480 |
Why?
|
| Leiomyosarcoma | 1 | 2014 | 40 | 0.480 |
Why?
|
| Postoperative Complications | 10 | 2022 | 2207 | 0.480 |
Why?
|
| Intestines | 2 | 2015 | 411 | 0.430 |
Why?
|
| Pouchitis | 2 | 2021 | 44 | 0.360 |
Why?
|
| Retrospective Studies | 20 | 2022 | 8489 | 0.360 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 184 | 0.340 |
Why?
|
| Antibodies, Monoclonal, Humanized | 3 | 2019 | 930 | 0.330 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 1169 | 0.320 |
Why?
|
| Humans | 41 | 2022 | 86643 | 0.310 |
Why?
|
| Quality of Life | 2 | 2019 | 1585 | 0.310 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 455 | 0.300 |
Why?
|
| Gastrointestinal Agents | 2 | 2019 | 161 | 0.290 |
Why?
|
| Neutrophils | 2 | 2006 | 307 | 0.270 |
Why?
|
| Focal Adhesions | 3 | 2017 | 69 | 0.270 |
Why?
|
| Treatment Outcome | 10 | 2020 | 7993 | 0.260 |
Why?
|
| Anastomosis, Surgical | 3 | 2022 | 267 | 0.250 |
Why?
|
| Fibronectins | 2 | 2006 | 93 | 0.240 |
Why?
|
| Adult | 20 | 2020 | 25648 | 0.240 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2003 | 16 | 0.240 |
Why?
|
| Integrin beta1 | 1 | 2003 | 33 | 0.230 |
Why?
|
| Male | 23 | 2021 | 40965 | 0.230 |
Why?
|
| Candidiasis | 1 | 2003 | 36 | 0.230 |
Why?
|
| Hypoalbuminemia | 1 | 2022 | 9 | 0.220 |
Why?
|
| NADPH Oxidases | 1 | 2003 | 81 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2020 | 683 | 0.220 |
Why?
|
| Operative Time | 3 | 2018 | 127 | 0.220 |
Why?
|
| Malnutrition | 1 | 2022 | 34 | 0.220 |
Why?
|
| Pressure Ulcer | 1 | 2022 | 42 | 0.210 |
Why?
|
| Female | 21 | 2020 | 44532 | 0.210 |
Why?
|
| Bacterial Infections | 1 | 2003 | 182 | 0.210 |
Why?
|
| Neoadjuvant Therapy | 2 | 2021 | 318 | 0.200 |
Why?
|
| Debridement | 2 | 2016 | 56 | 0.200 |
Why?
|
| Middle Aged | 17 | 2022 | 25028 | 0.190 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2020 | 19 | 0.190 |
Why?
|
| Surgical Stomas | 1 | 2020 | 22 | 0.180 |
Why?
|
| Ostomy | 2 | 2020 | 15 | 0.180 |
Why?
|
| Sepsis | 1 | 2003 | 306 | 0.180 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 103 | 0.180 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 3640 | 0.180 |
Why?
|
| Recurrence | 4 | 2021 | 1139 | 0.180 |
Why?
|
| Drug Substitution | 1 | 2019 | 25 | 0.170 |
Why?
|
| Postoperative Period | 3 | 2021 | 303 | 0.170 |
Why?
|
| Risk Factors | 7 | 2022 | 5417 | 0.170 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 71 | 0.170 |
Why?
|
| Colitis | 1 | 2021 | 239 | 0.160 |
Why?
|
| Surgeons | 1 | 2022 | 238 | 0.160 |
Why?
|
| Thrombospondins | 1 | 2017 | 14 | 0.150 |
Why?
|
| Caveolin 1 | 1 | 2017 | 20 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 556 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2017 | 62 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 162 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 339 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Aged | 8 | 2020 | 18415 | 0.150 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 36 | 0.140 |
Why?
|
| Blood Loss, Surgical | 3 | 2013 | 112 | 0.140 |
Why?
|
| Ileostomy | 2 | 2019 | 30 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2018 | 4213 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2015 | 839 | 0.140 |
Why?
|
| Intestinal Fistula | 1 | 2015 | 30 | 0.130 |
Why?
|
| Perineum | 1 | 2015 | 35 | 0.130 |
Why?
|
| Appendectomy | 1 | 2015 | 33 | 0.130 |
Why?
|
| Surgical Instruments | 1 | 2015 | 57 | 0.130 |
Why?
|
| Cost Savings | 1 | 2015 | 66 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2015 | 194 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 78 | 0.130 |
Why?
|
| Pelvic Floor | 1 | 2015 | 84 | 0.130 |
Why?
|
| Enterococcus faecalis | 1 | 2015 | 46 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Abdomen | 1 | 2015 | 122 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Intestinal Obstruction | 1 | 2015 | 88 | 0.130 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2014 | 18 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 191 | 0.120 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 30 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2016 | 125 | 0.120 |
Why?
|
| Portal Vein | 1 | 2014 | 120 | 0.120 |
Why?
|
| Collagen | 1 | 2015 | 269 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2017 | 534 | 0.110 |
Why?
|
| Suture Techniques | 1 | 2013 | 135 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2015 | 380 | 0.110 |
Why?
|
| Incidence | 2 | 2014 | 1577 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 237 | 0.100 |
Why?
|
| Length of Stay | 2 | 2013 | 702 | 0.100 |
Why?
|
| Pneumonectomy | 1 | 2014 | 196 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2017 | 751 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 243 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 243 | 0.100 |
Why?
|
| Microbiota | 1 | 2016 | 381 | 0.100 |
Why?
|
| Time Factors | 3 | 2013 | 5210 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 225 | 0.090 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2010 | 52 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 307 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 364 | 0.090 |
Why?
|
| Cross Infection | 1 | 2010 | 141 | 0.080 |
Why?
|
| Prognosis | 4 | 2020 | 3679 | 0.080 |
Why?
|
| Reoperation | 3 | 2019 | 597 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2019 | 91 | 0.080 |
Why?
|
| Focal Adhesion Kinase 2 | 2 | 2006 | 11 | 0.080 |
Why?
|
| Young Adult | 5 | 2019 | 5976 | 0.080 |
Why?
|
| Propensity Score | 2 | 2018 | 136 | 0.080 |
Why?
|
| src-Family Kinases | 2 | 2006 | 74 | 0.080 |
Why?
|
| Illinois | 2 | 2019 | 462 | 0.070 |
Why?
|
| Paxillin | 2 | 2006 | 59 | 0.070 |
Why?
|
| Remission Induction | 2 | 2019 | 722 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 1376 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2020 | 2767 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2004 | 692 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1805 | 0.070 |
Why?
|
| Phenotype | 2 | 2022 | 2378 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2015 | 746 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2004 | 46 | 0.060 |
Why?
|
| Fluconazole | 1 | 2003 | 10 | 0.060 |
Why?
|
| Peroxides | 1 | 2003 | 12 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 28 | 0.060 |
Why?
|
| Abdominal Cavity | 1 | 2003 | 18 | 0.060 |
Why?
|
| Laparotomy | 1 | 2003 | 59 | 0.060 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 31 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2004 | 270 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 231 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 286 | 0.060 |
Why?
|
| Colostomy | 1 | 2022 | 13 | 0.060 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2003 | 71 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2003 | 117 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 223 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 133 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2003 | 254 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 433 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 420 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 302 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 977 | 0.050 |
Why?
|
| Radiography | 1 | 2003 | 813 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 894 | 0.050 |
Why?
|
| United States | 3 | 2019 | 6672 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 999 | 0.050 |
Why?
|
| Biopsy | 1 | 2003 | 1163 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 15 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 301 | 0.040 |
Why?
|
| Adolescent | 3 | 2019 | 8981 | 0.040 |
Why?
|
| Vitamin D | 1 | 2021 | 261 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 159 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 777 | 0.040 |
Why?
|
| Biological Products | 1 | 2019 | 143 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 264 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 860 | 0.040 |
Why?
|
| Medical Records | 1 | 2017 | 119 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 920 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 468 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 1939 | 0.030 |
Why?
|
| Dehydration | 1 | 2015 | 18 | 0.030 |
Why?
|
| Intraabdominal Infections | 1 | 2015 | 10 | 0.030 |
Why?
|
| Anus Diseases | 1 | 2015 | 14 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 257 | 0.030 |
Why?
|
| Models, Economic | 1 | 2015 | 60 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 685 | 0.030 |
Why?
|
| Endoscopy | 1 | 2018 | 332 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2015 | 105 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 213 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 297 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 126 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 241 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
| Contrast Media | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 865 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1801 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 11 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 455 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 2013 | 24 | 0.030 |
Why?
|
| Ischemia | 1 | 2015 | 243 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 223 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 454 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1014 | 0.030 |
Why?
|
| Infliximab | 1 | 2013 | 151 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1197 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2261 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1239 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 554 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1384 | 0.030 |
Why?
|
| Chicago | 1 | 2016 | 1379 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2011 | 34 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 413 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1036 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2013 | 352 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2468 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 329 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1464 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3990 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 2438 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3241 | 0.020 |
Why?
|
| Detergents | 1 | 2006 | 34 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2006 | 32 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 133 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2004 | 7 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 65 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 54 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 88 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 92 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2004 | 209 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 286 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2006 | 645 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 428 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 1106 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 11352 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 444 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 26582 | 0.010 |
Why?
|